36 slides from Gr. Sarantis's investor presentation, May 2026
Slide 1: Sarantis Group Investors Presentation May 2026
Sarantis Group Investors Presentation May 2026
Slide 2: Forward-looking statement
Forward-looking statement This document contains certain “forward-looking” statements. These statements may generally, but not always, be identified by the use of words such as “outlook”, “forecast”, “objective”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “target”, “will”, “aim” and other
Slide 3: With you today
With you today Giannis Bouras Christos Varsos Group Chief Executive Officer Group Chief Financial Officer 3 Sarantis Group Investors Presentation
Slide 4: Strategic Overview
Strategic Overview Giannis Bouras, Group Chief Executive Officer
Slide 5: A long history of over 60 years
A long history of over 60 years 2015 Milestone acquisitions: 1964 Establishment of 1994 New production facilities Polipak, Ergopack, Stella GR. SARANTIS S.A. 2000 in Athens 2025 Pack Expansion in Eastern Investments in Europe infrastructure New exclusive strategic agreements Intense Acquisition List
Slide 6: Reinforcing our strategic foundations
Reinforcing our strategic foundations OUR COMPETITIVE ADVANTAGE OUR SCOPE ▪ We design for the CEE region with deep local consumer understanding ▪ CEE and Selected International Markets on beauty ▪ We are the revitalisers of local “jewel” brands ▪ Beauty, Skin and Sun Care ▪ We invest in infrastructu
Slide 7: Consistent organic growth with acquisitions coming on top
Consistent organic growth with acquisitions coming on top Sarantis Group Growth Drivers Beauty, Skin & Personal Home Care Strategic Sun Care Care Solutions Partnerships Disproportionate Core Profit Significant growth driver Market leverage growth Generator Complementary acquisitions on top in key pr
Slide 8: Branded Business outperformed Private Label amid mixed category dynamics
Branded Business outperformed Private Label amid mixed category dynamics NET SALES FY 2025 %Δ FY 2024 NET SALES CONTRIBUTION FY 2025 Branded € 548.6m + 1.5% € 540.3m % Δ y-o-y TO TOTAL SALES Business* Beauty, Skin € 73.1m 12.2% & Sun Care + 21.3% Private Label € 51.0m - 14.6% € 59.8m Personal € 112.
Slide 9: Advancing in key geographies across varied market conditions
Advancing in key geographies across varied market conditions FY 2025 NET SALES CONTRIBUTION TO % Δ y-o-y TOTAL SALES Greece € 152.8m (domestic market) + 1.0% 25.5% Selected € 30.8m international markets + 60.0% 5.1% Poland € 175.9m - 4.5% 29.3% Romania € 93.9m - 5.1% 15.7% Czech, Slovakia & € 63.6m
Slide 10: International expansion gaining tangible traction
International expansion gaining tangible traction Growth Drivers for Exports Expansion of international markets portfolio Beauty, Skin & Suncare USA #1 in Tanning Category at Oils and Lotions Expanding footprint and market reach in Amazon US continued strengthening of in-store #100 in Beauty and Per
Slide 11: Delivering on our strategic transformation agenda
Delivering on our strategic transformation agenda DIGITAL TRANSFORMATION MANUFACTURING UPGRADE ESG ▪ New SAP implementation: Building a ▪ Stella Pack regranulation upgrade ▪ Improving ESG ratings supported by unified data platform across markets completed in 2025 to drive efficiency, disciplined bus
Slide 12: Strengthening ESG performance through execution and engagement
Strengthening ESG performance through execution and engagement Improved to Medium Risk category (from High Risk previously) Overall risk improved to Medium (from High previously), with strongest progress in Governance ESG ratings improving supported by business plan execution and ongoing engagement
Slide 13: Well-placed for Sustainable Growth
Well-placed for 13 Sustainable Growth 2X EBITDA to €120m *Net Sales €620m 2X EBIT to €95m EBITDA €89.0m *EBITDA €97m Net Sales €600.1m EBIT €67.0m from 2023 Net Sales €482.2m EBITDA €81.6m Net Sales €445.1m EBITDA €61.6m EBIT €61.0m √ EBITDA €45.5m EBIT €47.1m EBIT €32.2m √ 2022 2023 2024 2025 2026
Slide 14: Financial Performance
Financial Performance Christos Varsos, Group Chief Financial Officer
Slide 15: Strong first-quarter performance
Strong first-quarter performance Q1 2026 Net Sales € 147.1m Robust Financial Position + 3.7% Net debt € 5.5m Q1 2026 EBITDA as of March 31, 2026 € 23.3m (vs €5.7m Net cash as of March 31, 2025*) + 19.9% *benefited from the €20.6m installment from Estée Lauder, with the final installment expected in
Slide 16: Solid sales with strong delivery in profitability
Solid sales with strong delivery in profitability Consolidated Statement of Comprehensive income Amounts In €m FY 2025 FY 2024 Δ (unless otherwise stated) Net Sales 599.6 600.1 - 0.1% Gross Profit 222.5 226.2 - 1.7% Gross Profit margin 37.1% 37.7% - 59bps EBITDA 89.0 81.6 9.1% EBITDA margin 14.8% 13
Slide 17: Strong profitability in strategic growth categories
Strong profitability in strategic growth categories FY 2025 figures NET SALES EBIT EBIT % % Δ y-o-y % Δ y-o-y Δ y-o-y Beauty, Skin € 73.1m € 17.5m 24.0% & Sun Care + 21.3% + 98.2% + 931bps Personal € 112.3m € 17.5m 15.6% Care - 3.8% - 1.6% + 35bps Home Care € 205.5m € 22.1m 10.7% Solutions - 3.3% -
Slide 18: Solid performance in key markets
Solid performance in key markets FY 2025 figures NET SALES EBIT EBIT% %Δ y-o-y %Δ y-o-y Δ y-o-y € 152.8m € 18.7m 12.2% Greece + 1.0% + 12.3% + 123bps Selected € 30.8m € 11.2m 36.3% international markets + 60.0% + 122.5% + 1,022bps NET SALES EBIT EBIT% %Δ y-o-y %Δ y-o-y Δ y-o-y € 175.9m € 9.4m 5.3% €
Slide 19: Balance sheet strength and financial flexibility
Balance sheet strength and financial flexibility ▪ Balance sheet empowers financial strength and flexibility to ▪ invest organically ▪ support the transformation of the Group ▪ fuel M&A activity ▪ Robust financial position with net cash of €23.5m ▪ Operational working capital improvement as of 31.12
Slide 20: Driving long-term shareholder value
Driving long-term shareholder value Board’s proposal to AGM for 2025 dividend payment €25.0m +25.0% to PY €0.39 per share Dividend payout ratio 47.1% EPS €0.83 vs 43.5% in the PY + 17.0% Share buy-back Cancelation of program treasury stocks in place as of June 19th, 2025 20 Sarantis Group Investors
Slide 21: CAPEX framework and execution priorities
CAPEX framework and execution priorities Capex 2024 2025 2026e 2027e 2028e Digital* € 6.0m € 6.5m € 4.5m € 1.0m € 1.0m transformation Stella Pack € 3.0m € 15.0m € 3.7m € 1.0m € 1.0m Oinofyta plant € 5.3m € 7.2m € 1.0m € 1.0m expansion Rest of Group € 8.5m € 10.5m € 4.6m € 7.0m € 7.0m Total € 17.5m €
Slide 22: Full Year 2026 Outlook
Full Year 2026 Outlook 2026 Net Sales at €620m + 3.4% vs 2025 2026 EBITDA at €97m + 9.0% vs 2025 EBITDA % at 15.6% +76bps vs 2025 CAPEX €20m expected for 2026 FCF €63m expected for 2026 22 Sarantis Group Investors Presentation
Slide 23: Delivering Strong Shareholder Value
Delivering Strong Shareholder Value 5-Year Plan* *as communicated during the Investor Day in March 2024
Slide 24: Disproportional growth on Beauty, Skin & Sun Care
Disproportional growth on Beauty, Skin & Sun Care CAGR Net Sales (€m) 2023 2024* 2025 2026 2027 2028 2023-2028 Own brands 349.6 454.3 481.7 509.0 537.7 568.7 10.2% Beauty, Skin & Sun Care 48.2 57.2 70.0 77.7 87.1 99.7 15.7% Personal Care 102.8 108.1 112.7 √ 120.1 127.8 134.9 5.6% Home Care 198.7 288
Slide 25: Doubling the EBITDA Organically in the next 5 years
Doubling the EBITDA Organically in the next 5 years (€m) 2023 2024* 2025 2026 2027 2028 Net Sales 482.2 595.2 627.9 662.5 698.9 737.4 %YoY 23.5% 5.5% 5.5% 5.5% 5.5% Gross Margin 182.0 225.1 239.3 254.5 270.6 287.6 % on NS 37.8% 37.8% 38.1% 38.4% 38.7% 39.0% A&P 28.6 33.9 37.2 40.6 41.5 42.4 % on NS
Slide 26: Why Sarantis has a strong Investment Case
Why Sarantis has a strong Investment Case ▪ Sustainable organic growth engine 01 ▪ Leading presence in our geographies ▪ Strong brand portfolio in the right categories ▪ Strong supply chain footprint with continuous investment plan 2X EBITDA in 5 years from 2023 ▪ 02 ▪ Consistent dividend > 38% payo
Slide 27: ESG Strategy
ESG Strategy
Slide 28: Raising Corporate Governance Standards
Raising Corporate Governance Standards Strengthening Board Independence & All Committees comprise of Non-Executive Directors and are chaired by Independent Non-Executive directors. Gender Diversity Michalis Imellos Eight-member Board of Directors Audit Committee Independent Non-Executive Director *
Slide 29: Committing to Science-Based Targets initiative (SBTi)-aligned targets
Committing to Science-Based Targets initiative (SBTi)-aligned targets We align our strong financial performance with measurable sustainability initiatives that drive business value 2023 2026 2027 2030 2050 we commit to setting a we commit to Net-zero mid-term CO2 scope 3 carbon footprint across the
Slide 30: Appendix
Appendix
Slide 31: Our brands
Our brands Beauty, Skin & Sun Care Personal Care
Slide 32: Our brands – Home Care Solutions
Our brands – Home Care Solutions
Slide 33: Strategic Partnerships – Mass Distribution
Strategic Partnerships – Mass Distribution
Slide 34: Strategic Partnerships – Selective Distribution
Strategic Partnerships – Selective Distribution Premium/ Niche brands
Slide 35: Recent Acquisitions
Recent Acquisitions 2014 2015 2015 2018 2018 2020 2024 Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition ✓ Cosmetics brand ✓ Hand-dishwashing ✓ Production of PL ✓ Cosmetics brand ✓ Leading player in the ✓ Cosmetics br
Slide 36: Q&A
Q&A For further information on Sarantis Group please visit our website at https://sarantisgroup.com/ or contact our Investor Relations team: Gr-ir@sarantisgroup.com +30 210 6173065